Ola Skanung - Cyxone AB CEO

CYXO Stock  SEK 0.14  0.01  7.69%   

CEO

Mr. Ola Skanung serves as Chief Financial Officer at Cyxone AB. He has a background as Bachelor of Business Administration, major in entrepreneurship, with further studies in change management and audit. He also has many years of experience as a CFO and experience from working with growing companies. since 2019.
Age 59
Tenure 5 years
Phone46 7 08 88 21 72
Webhttps://www.cyxone.com

Cyxone AB Management Efficiency

The company has return on total asset (ROA) of (0.5861) % which means that it has lost $0.5861 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0658) %, meaning that it generated substantial loss on money invested by shareholders. Cyxone AB's management efficiency ratios could be used to measure how well Cyxone AB manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Found 2 records

CEO Age

Martin WelschofBioInvent International AB
62
Goran ForsbergCantargia AB
60
Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple sclerosis and treatments for virally induced acute respiratory disorders. The company was founded in 2015 and is headquartered in Malm, Sweden. Cyxone AB is traded on Stockholm Stock Exchange in Sweden. Cyxone AB (CYXO) is traded on Stockholm Exchange in Sweden and employs 8 people.

Management Performance

Cyxone AB Leadership Team

Elected by the shareholders, the Cyxone AB's board of directors comprises two types of representatives: Cyxone AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cyxone. The board's role is to monitor Cyxone AB's management team and ensure that shareholders' interests are well served. Cyxone AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cyxone AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
Malin Berthold, Project Manager
Theresa Olsen, Director
Bert Junno, Chairman of the Board
Ola Skanung, Interim Chief Executive Officer, Chief Financial Officer
Mikael Lindstam, Chief Operating Officer, Director
Erika Samuelsson, Chief Officer
Saad Gilani, Director
CarlMagnus Hogerkorp, COO CEO

Cyxone Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cyxone AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Cyxone AB

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyxone AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyxone AB will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cyxone Stock

  0.7CAMX Camurus ABPairCorr
  0.83HNSA Hansa Biopharma ABPairCorr

Moving against Cyxone Stock

  0.78AINO Aino Health ABPairCorr
  0.71NANOFS Nanoform Finland PlcPairCorr
  0.59AERO Svenska Aerogel Holding Earnings Call TodayPairCorr
  0.55RO Rolling Optics HoldingPairCorr
  0.36AEGIR Aegirbio ABPairCorr
The ability to find closely correlated positions to Cyxone AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyxone AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyxone AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyxone AB to buy it.
The correlation of Cyxone AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyxone AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyxone AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyxone AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Cyxone Stock Analysis

When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.